Michael Kalafatis

3.9k total citations
91 papers, 3.1k citations indexed

About

Michael Kalafatis is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Michael Kalafatis has authored 91 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Hematology, 32 papers in Genetics and 15 papers in Molecular Biology. Recurrent topics in Michael Kalafatis's work include Blood Coagulation and Thrombosis Mechanisms (76 papers), Hemophilia Treatment and Research (57 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (31 papers). Michael Kalafatis is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (76 papers), Hemophilia Treatment and Research (57 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (31 papers). Michael Kalafatis collaborates with scholars based in United States, Italy and Netherlands. Michael Kalafatis's co-authors include Kenneth G. Mann, Matthew D. Rand, K G Mann, Paolo Simioni, Rogier M. Bertina, Paula B. Tracy, KG Mann, J.H. Lawson, Cornelis van ′t Veer and Michael A. Bukys and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Biochemistry.

In The Last Decade

Michael Kalafatis

89 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Kalafatis United States 32 2.7k 1.1k 345 313 308 91 3.1k
Evgueni L. Saenko United States 34 2.8k 1.0× 791 0.8× 86 0.2× 39 0.1× 761 2.5× 95 3.6k
Glenn Merrill‐Skoloff United States 15 1.5k 0.5× 273 0.3× 509 1.5× 20 0.1× 605 2.0× 25 2.8k
David Siemieniak United States 17 951 0.3× 422 0.4× 18 0.1× 473 1.5× 644 2.1× 35 2.6k
Qiufang Cheng United States 19 815 0.3× 958 0.9× 69 0.2× 370 1.2× 177 0.6× 34 1.3k
Andrew C. Pearce United Kingdom 25 1.2k 0.4× 176 0.2× 80 0.2× 12 0.0× 632 2.1× 37 2.4k
Anja Leyte Netherlands 19 534 0.2× 226 0.2× 175 0.5× 23 0.1× 523 1.7× 35 1.4k
John D. Kulman United States 16 481 0.2× 118 0.1× 47 0.1× 181 0.6× 276 0.9× 27 1.0k
Brenda M. Luken Netherlands 20 720 0.3× 389 0.4× 51 0.1× 16 0.1× 213 0.7× 29 1.4k
Harry A.M. Andree United States 13 640 0.2× 54 0.1× 73 0.2× 30 0.1× 727 2.4× 17 1.8k
Pascale Cornillet‐Lefèbvre France 23 931 0.3× 328 0.3× 60 0.2× 6 0.0× 793 2.6× 49 2.0k

Countries citing papers authored by Michael Kalafatis

Since Specialization
Citations

This map shows the geographic impact of Michael Kalafatis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Kalafatis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Kalafatis more than expected).

Fields of papers citing papers by Michael Kalafatis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Kalafatis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Kalafatis. The network helps show where Michael Kalafatis may publish in the future.

Co-authorship network of co-authors of Michael Kalafatis

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Kalafatis. A scholar is included among the top collaborators of Michael Kalafatis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Kalafatis. Michael Kalafatis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hirbawi, Jamila, et al.. (2025). Quercetin Increases Expression of Membrane-TRAIL in Glioblastoma Cells Resulting in Apoptosis. Cancers. 17(19). 3197–3197.
2.
Kalafatis, Michael, et al.. (2023). Exploring the anti-cancer effects of Panax notoginseng through network pharmacology and molecular modeling. Genes & Diseases. 10(6). 2229–2232. 1 indexed citations
3.
4.
Hirbawi, Jamila, et al.. (2015). The Dual Regulatory Role of Amino Acids Leu480 and Gln481 of Prothrombin. Journal of Biological Chemistry. 291(4). 1565–1581. 1 indexed citations
5.
Hirbawi, Jamila, et al.. (2013). Amino Acid Region 1000–1008 of Factor V Is a Dynamic Regulator for the Emergence of Procoagulant Activity. Journal of Biological Chemistry. 288(52). 37026–37038. 3 indexed citations
6.
Bukys, Michael A., et al.. (2008). The contribution of amino acid residues 1508–1515 of factor V to light chain generation. Journal of Thrombosis and Haemostasis. 6(1). 118–124. 7 indexed citations
7.
Bukys, Michael A., Paul Y. Kim, Michael E. Nesheim, & Michael Kalafatis. (2006). A Control Switch for Prothrombinase. Journal of Biological Chemistry. 281(51). 39194–39204. 23 indexed citations
8.
Kalafatis, Michael. (2005). Coagulation factor V: a plethora of anticoagulant molecules. Current Opinion in Hematology. 12(2). 141–148. 27 indexed citations
9.
Bukys, Michael A., et al.. (2005). Incorporation of Factor Va into Prothrombinase Is Required for Coordinated Cleavage of Prothrombin by Factor Xa. Journal of Biological Chemistry. 280(29). 27393–27401. 30 indexed citations
10.
Hung, Kevin, Xue‐Long Sun, Heyuan Ding, et al.. (2002). A matrix-assisted laser desorption/ionization time-of-flight based method for screening the 1691G → A mutation in the factor V gene. Blood Coagulation & Fibrinolysis. 13(2). 117–122. 9 indexed citations
11.
12.
Long, George L., Deshun Lu, Ronglin Xie, & Michael Kalafatis. (1998). Human Protein S Cleavage and Inactivation by Coagulation Factor Xa. Journal of Biological Chemistry. 273(19). 11521–11526. 33 indexed citations
13.
Kalafatis, Michael. (1998). Identification and Partial Characterization of Factor Va Heavy Chain Kinase from Human Platelets. Journal of Biological Chemistry. 273(14). 8459–8466. 21 indexed citations
14.
Veer, Cornelis van ′t, Michael Kalafatis, Rogier M. Bertina, Paolo Simioni, & Kenneth G. Mann. (1997). Increased Tissue Factor-initiated Prothrombin Activation as a Result of the Arg506 → Gln Mutation in Factor VLEIDEN. Journal of Biological Chemistry. 272(33). 20721–20729. 47 indexed citations
15.
Egan, Jack O., Michael Kalafatis, & Kenneth G. Mann. (1997). The effect of Arg306 → Ala and Arg506 → Gln substitutions in the inactivation of recombinant human factor Va by activated protein C and protein S. Protein Science. 6(9). 2016–2027. 38 indexed citations
16.
Kalafatis, Michael, Rogier M. Bertina, Matthew D. Rand, & Kenneth G. Mann. (1995). Characterization of the Molecular Defect in Factor VR506A. Journal of Biological Chemistry. 270(8). 4053–4057. 192 indexed citations
17.
Camire, Rodney M., Michael Kalafatis, Mary Cushman, et al.. (1995). The Mechanism of Inactivation of Human Platelet Factor Va from Normal and Activated Protein C-resistant Individuals. Journal of Biological Chemistry. 270(35). 20794–20800. 90 indexed citations
18.
Kalafatis, Michael, Matthew D. Rand, & Kenneth G. Mann. (1994). Factor Va-membrane interaction is mediated by two regions located on the light chain of the cofactor. Biochemistry. 33(2). 486–493. 44 indexed citations
19.
Kalafatis, Michael, et al.. (1993). Determination of the disulfide bridges in factor Va light chain. Biochemistry. 32(22). 5917–5923. 17 indexed citations
20.
Kalafatis, Michael, Sriram Krishnaswamy, Matthew D. Rand, & Kenneth G. Mann. (1993). [13] Factor V. Methods in enzymology on CD-ROM/Methods in enzymology. 222. 224–236. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Evgueni L. Saenko Breakdown of academic impact, for papers by Glenn Merrill‐Skoloff Breakdown of academic impact, for papers by David Siemieniak Breakdown of academic impact, for papers by Qiufang Cheng Breakdown of academic impact, for papers by Andrew C. Pearce Breakdown of academic impact, for papers by Anja Leyte Breakdown of academic impact, for papers by John D. Kulman Breakdown of academic impact, for papers by Brenda M. Luken Breakdown of academic impact, for papers by Harry A.M. Andree Breakdown of academic impact, for papers by Pascale Cornillet‐Lefèbvre
Rankless by CCL
2026